Vivesto Stock

Vivesto Equity

The The Equity of Vivesto (VIVE.ST) as of Aug 14, 2026 is 197.80 M SEK. In the previous year, The Equity was 325.42 M SEK — a change of -39.22% (lower).

Equity

197.80 MSEK

YoY

-39.22%

Last updated:

In 2026, Vivesto's equity was 197.80 M SEK, a -39.22% increase from the 325.42 M SEK equity in the previous year.

Access this data via the Eulerpool API

Vivesto Stock analysis

What does Vivesto do? Oasmia Pharmaceutical AB is a Swedish pharmaceutical company that specializes in the development and marketing of innovative cancer and pain medications. The company was founded in 1998 and is headquartered in Uppsala, Sweden. Vivesto is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Vivesto's Equity

Vivesto's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Vivesto's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Vivesto's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Vivesto's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Vivesto’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Vivesto stock

The Equity of Vivesto is 197.80 M SEK in 2026.

The Equity of Vivesto changed from 325.42 M SEK to 197.80 M SEK, representing a -39.22% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Vivesto since 2006 – with annual values, charts, and detailed analysis.

The Equity's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Vivesto historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Vivesto

All Key Metrics — Vivesto